Evidence map›Paper›PMID 30314489›Full record

ArticleMalaria journal2018

Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia.

Guillermo Martínez-Pérez, Dawoh Peter Lansana, Senga Omeonga, Himanshu Gupta, Bondey Breeze-Barry, Raquel González, Azucena Bardají, Adelaida Sarukhan, James D K Goteh, Edith Tody and 8 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Guillermo Martínez-PérezISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. gmartinezgabas@gmail.com.ORCID http://orcid.org/0000-0001-6756-9515
Dawoh Peter LansanaSaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Senga OmeongaSaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Himanshu GuptaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Bondey Breeze-BarrySaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Raquel GonzálezISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Azucena BardajíISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Adelaida SarukhanISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
James D K GotehLiberia Medicines and Health Products Regulatory Authority, Monrovia, Liberia.
Edith TodySaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Pau CisteróISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Benard BendaSaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Juwe D KerculaLiberia Medicines and Health Products Regulatory Authority, Monrovia, Liberia.
Fanta D KibunguSaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Ana Meyer García-SípidoNGO Juan Ciudad Foundation, Madrid, Spain.
Quique BassatISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Christine K Tarr-AttiaSaint Joseph's Catholic Hospital, Oldest Congo Town, PO Box 10-512, 1100, Monrovia, Liberia.
Alfredo MayorISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Barcelona Institute for Global Health · ESNational Public Health Institute of Liberia · LRInstitució Catalana de Recerca i Estudis Avançats · ESManhiça Health Research Centre · MZSt. Joseph Hospital · US

Funding

European and Developing Countries Clinical Trials Partnership EDCTP Ebola-CSA-334
6 · The paper itself

Abstract

backgroundDisruption of malaria control strategies during the West African 2014-2016 Ebola epidemic led to an increase in malaria-attributable mortality. However, recent data on malaria infection in vulnerable groups, such as pregnant women, are lacking in this post-Ebola scenario. This cross-sectional study aimed to assess the prevalence of Plasmodium falciparum infection and of molecular markers of drug resistance among pregnant women attending antenatal care in Monrovia, capital of Liberia.

methodsFrom October 2016 to June 2017, all pregnant women attending their first antenatal care visit at the Saint Joseph's Catholic Hospital, Monrovia, were invited to participate in the study. In addition to their routine antenatal care tests, capillary blood spotted onto filter papers were collected from all consenting participants to determine presence of P. falciparum by real-time quantitative PCR. Molecular markers of anti-malarial drug resistance were assessed through Sanger sequencing and quantitative PCR in specimens positive for P. falciparum analysis.

resultsOf the 195 women participants, 24 (12.3%) were P. falciparum-positive by qPCR. Infected women tended to be more commonly primigravidae and younger than uninfected ones. Parasite densities were higher in primigravidae. Fever was more frequently detected among the infected women. No statistically significant association between P. falciparum infection and haemoglobin levels or insecticide-treated net use was found. While high prevalence of genetic polymorphisms associated with chloroquine and amodiaquine resistance were detected, no molecular markers of artemisinin resistance were observed.

conclusionPlasmodium falciparum infections are expected to occur in at least one in every eight women attending first ANC at private clinics in Monrovia and outside the peak of the rainy season. Young primigravidae are at increased risk of P. falciparum infection. Molecular analyses did not provide evidence of resistance to artemisinins among the P. falciparum isolates tested. Further epidemiological studies involving pregnant women are necessary to describe the risk of malaria in this highly susceptible group outside Monrovia, as well as to closely monitor the emergence of resistance to anti-malarials, as recommended by the Liberian National Malaria Control Programme.

Indexed as

Drug ResistancePrenatal CareAdolescentAdultAntimalarialsFemaleHumansLiberiaMalaria, FalciparumPlasmodium falciparumPregnancyPregnancy Complications, ParasiticPrevalenceYoung AdultAntimalarialsAntenatalLiberiaMalariaParasite resistancePregnancyPrevalence

Identifiers

PMID30314489
PMCPMC6186138
OpenAlexW2896092009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.